Wed 2 Dec 2009 | 15:25 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For ARYx Therapeutics, Inc.

ARYx Therapeutics, Inc. (ARYX.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Biotechnology ยท View ARYX on other exchanges
As of  2:53pm EST
2.67USD
Price Change
+0.05
Percent Change
+1.91%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Canafax, Daniel 56 2007 Vice President, Chief Development Officer
Nagler, David 56 2003 Vice President - Corporate Affairs, Secretary
Druzgala, Pascal 54 2008 Senior Vice President, Chief Scientific Officer
Milner, Peter 53 2005 President - Research and Development, Director
Ekman, Lars 59 2003 Director
Leonard, Keith 47 2005 Director
Rosenman, Herm 61 2006 Director
Sekhri, Paul 50 2004 Director
Simon, Nicholas 54 2002 Director
Beier, David 60 2008 Director
Varian, John 49 2006 Chief Financial Officer, Chief Operating Officer
Goddard, Paul 59 2005 Chairman of the Board, Chief Executive Officer